Guest Editor(s)
-
- Dr. Maurizio Taramasso, PhD
- Cardiac Surgery Department, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
Website | E-mail
-
- Dr. Ana Paula Tagliari, PhD
- Cardiac Surgery Department, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
Website | E-mail
Special Issue Introduction
Since the first human TAVI performed by Professor Alain Cribier in 2002, a lot of innovations and improvements have led to the widespread use of transcatheter aortic valve techniques. In the last years, we have seen a staggering increase in the volume of TAVI procedures, patients starting to ask for TAVI instead of traditional open cardiac surgery, and the approval of TAVI for low-risk populations. All these achievements were possible just because the procedure proved itself to be safe, effective, and reproducible.
Right now, we are writing the next chapters of TAVI's history, which hopefully will be so successful as the previous ones. However, to achieve a new step in the TAVI field, we need to understand the limitations and challenges of this method. With this idea in mind, we decided to produce this special issue, focusing on the following topics: TAVI in low-risk patients; TAVI combined with other transcatheter interventions in patients with concomitant cardiac diseases; Routine use of cerebral protection devices during TAVI; Valve-in-valve therapy and special situations; Neo-commissure alignment to mimic a more physiologic valve implantation.
We expect that, through this special issue, we can clarify some of these topics, providing new insights, and updating perspectives to optimize TAVI procedures.
Keywords
Transcatheter aortic valve implantation, cerebral protection devices, coronary obstruction, neo-commissure alignment
Submission Deadline
31 Aug 2020